HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
NCT03603405
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
62
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Anaplastic Astrocytoma
Interventions
DRUG:
ADV/HSV-tk (gene therapy)
Sponsor
The Methodist Hospital Research Institute